Long-term bone marrow culture profiles in patients with myelodysplastic syndromes are not explicable by defective apoptosis

Leukemia Research

Volumn 22, Issue 8, 1998, Pages 735-740

  McMullin, M F ^a   Buckley, O ^a   Magill, M K ^a   Irvine, A E ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Apoptosis; Long term bone marrow culture; Myelodysplastic syndromes

Indexed keywords

APOPTOSIS; ARTICLE; BONE MARROW CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

APOPTOSIS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; HUMANS; MYELODYSPLASTIC SYNDROMES; TUMOR CELLS, CULTURED;

EID: 0031814583     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00066-6     Document Type: Article

References (27)

1. Yoshida Y. Hypothesis: Apoptosis may be the mechanism for the premature intramedullary cell death in the myelodysplastic syndrome. Leukemia. 7:1993;144.
2. Clark D.M., Lampert I.A. Apoptosis is a common histopathological finding in myelodysplasia: The correlate of ineffective haematopoiesis. Leuk Lymphoma. 2:1990;415.
3. Bogdanovic A.D., Jankovic G.M., Colovic M.D. Apoptosis in the bone marrow of myelodysplastic syndrome patients. Blood. 87:1996;3064.
4. Raza A., Mundle S., Iftikhar A., Gregory S., Marcus B., Khan Z., Alvi S., Shetty V., Dameron S., Wright V., Adler S., Loew J.M., Shott S., Ali S.N., Preisler H. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplasia reveals extensive apoptosis as the probable basis for ineffective haematopoiesis. Am J Haematol. 48:1995;143.
5. Raza A., Gezer S., Mundle S., Gao X-Z., Alvi S., Borok R., Rifkin S., Iftikar A., Shelty V., Parcharidou A., Loew J., Marcus B., Khan Z., Chaney C., Showel J., Gregory S., Preisler H. Apoptosis in bone marrow biopsy samples involving stromal and hemopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 86:1995;268.
6. Irvine A.E., Magill M.K., Somerville L.E., McMullin M.F. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia. Exp Haematol. 26:1998;435.
7. Milner G.R., Testa N.G., Geary C.G., Dexter T.M., Mudal S., MacIvor J.E., Lajtha L.G. Bone marrow culture studies in refractory cytopenia and smouldering leukaemia. Br J Haematol. 35:1977;251.
8. May S.J., Smith S.A., Jacobs A., Williams A., Bailey-Wood R. The myelodysplastic syndromes: Analysis of laboratory characteristics in relation to the FAB classification. Br J Haematol. 59:1985;311.
9. Chui D.H.K., Clarke B.J. Abnormal erythroid progenitor cells in human preleukemia. Blood. 60:1982;362.
10. Juvonen E., Partanen S., Knuutila S., Ruutu T. Megakarocyte colony formation by bone marrow in myelodysplastic syndromes. Br J Haematol. 63:1986;331.
11. Tennant G.B., Bowen D.T., Jacobs A. Colony-cluster ratio and cluster number in cultures of circulating myeloid progenitors as indicators of high-risk myelodysplasia. Br J Haematol. 77:1991;296.
12. Roberts I.A.G., McMullin M.F. A practical miniature long-term bone marrow culture system for investigating early myelodysplasia. Leuk Res. 16:1992;737.
13. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493.
14. Lepelley P., Campergue L., Grardel N., Preudhomme C., Cossan A., Fenaux P. Is apoptosis a massive process in myelodysplastic syndromes? Br J Haematol. 95:1996;368.
15. Borbenyi Z., Cinkotai C., Harrison C., Testa N.G. The growth of myelodysplastic bone marrow in long-term cultures. Br J Cancer. 55:1987;291.
16. Marley S.B., Russell N.H., Reilly I.A.G. GM-CSF stimulates blast cell proliferation in long-term culture of bone marrow from patients with myelodysplasia. Leuk Lymphoma. 2:1990;291.
17. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H.P., Toyka K.V., Lassman H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest. 71:1994;219.
18. Mundle S.D., Raza A. The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis. Lab Invest. 72:1995;611.
19. Mundle S.D., Gao X.Z., Khan S., Gregory S.A., Preisler H.D., Raza A. Two in situ labeling techniques reveal different patterns of DNA fragmentation during spontaneous apoptosis in vivo and induced apoptosis in vitro. Anticancer Res. 15:1995;1895.
20. Won J-H., Hong D-S., Suh W-S., Baick S-H., Kim S-J., Park H-S., Lee J-S. Evaluation of haematopoietic abnormalities and apoptosis using long term bone marrow culture system and in situ nick end labeling method in myelodysplastic syndrome. Br J Haematol. 93(suppl 2):1996;67.
21. Bendall L.J., Daniel A., Kortlepel K., Gottlieb D.J. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. Exp Haematol. 22:1994;1252.
22. Bouscary D., De Vos J., Guesnu M., Jondeau K., Viguier F., Melle J., Picard F., Dreyfus F., Fontenay-Roupie M. Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia. 11:1997;839.
23. Gersuk G.M., Lee J.W., Beckham C.A., Anderson J., Deeg H.J. Fas (CD 95) receptor and fas ligand expression in bone marrow cells from patients with myelodysplastic syndromes. Blood. 88:1996;1122.
24. Delia D., Aiello A., Soligo D., Fontanella E., Melani C., Pezzella F., Pierotti M.A., Della Porta G. Bcl-2 proto-oncogene expression in normals and neoplastic human myeloid cells. Blood. 82:1992;1092.
25. Lepelley P., Soenen V., Preudhomme C., Merlat A., Cosson A., Fenaux P. Bcl-2 expression in myelodysplastic syndromes and it's correlation with haematological features, p53 mutations and prognosis. Leukemia. 9:1995;726.
26. Callera F., Falcao R.P. Increased apoptotic cells in bone marrow biopsies from patients with aplastic anaemia. Br J Haematol. 98:1997;18.
27. Yuan J., Angelucci E., Lucarelli G., Aljurf M., Snyder L.M., Kiefer C.R., Ma L., Schrier S.L. Accelerated programmed cell death (apoptosis) in erythroid precursors with severe B-thalassemia (Cooley's anemia). Blood. 82:1993;374.